Astrana Health, Inc. · NASDAQ (us_market)
Healthcare · Medical Care Facilities · United States
Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2025-10-28$33.89 RISE2026-02-12$18.16 PEAK2026-05-08$39.30 192d | -46.4% 107d | Missed | Missed | — | — | +116.4% 85d | Missed |
DROP2025-10-28$33.89 RISE2025-11-20$20.34 PEAK2026-01-12$29.21 76d | -40.0% 23d | Missed | Missed | — | — | +43.6% 53d | Missed |
DROP2025-08-29$31.96 RISE2025-09-22$27.08 PEAK2025-10-28$33.89 60d | -15.3% 24d | Missed | Missed | — | — | +25.1% 36d | Missed |
DROP2025-04-14$34.05 RISE2025-08-07$21.46 PEAK2025-10-28$33.89 197d | -37.0% 115d | Missed | Missed | — | — | +57.9% 82d | Missed |
DROP2024-10-17$61.37 RISE2025-02-28$25.38 PEAK2025-04-14$34.05 179d | -58.6% 134d | Missed | Missed | — | — | +34.2% 45d | Missed |
DROP2024-10-16$62.54 RISE2025-01-10$29.48 PEAK2025-02-13$39.20 120d | -52.9% 86d | Missed | Missed | — | — | +33.0% 34d | Missed |
DROP2024-02-29$45.04 RISE2024-07-10$38.20 PEAK2024-10-03$59.48 217d | -15.2% 132d | Missed | Missed | — | — | +55.7% 85d | Missed |
DROP2024-02-29$45.04 RISE2024-04-25$36.56 PEAK2024-07-23$51.23 145d | -18.8% 56d | Missed | Missed | — | — | +40.1% 89d | Missed |
DROP2023-08-10$39.33 RISE2023-11-06$29.34 PEAK2023-12-27$40.17 139d | -25.4% 88d | Missed | Missed | — | — | +36.9% 51d | Missed |
DROP2023-08-10$39.33 RISE2023-09-22$29.94 PEAK2023-12-14$36.94 126d | -23.9% 43d | Missed | Missed | — | — | +23.4% 83d | Missed |
DROP2023-04-19$40.28 RISE2023-06-26$29.55 PEAK2023-08-10$39.33 113d | -26.6% 68d | Missed | Missed | — | — | +33.1% 45d | Missed |
DROP2022-08-10$51.14 RISE2022-12-15$27.17 PEAK2023-03-03$38.03 205d | -46.9% 127d | Missed | Missed | — | — | +40.0% 78d | Missed |
DROP2022-08-03$56.87 RISE2022-10-14$31.50 PEAK2022-11-04$37.95 93d | -44.6% 72d | Missed | Missed | — | — | +20.5% 21d | Missed |
DROP2021-12-31$73.48 RISE2022-05-11$30.56 PEAK2022-08-03$56.87 215d | -58.4% 131d | Missed | Missed | — | — | +86.1% 84d | Missed |
DROP2021-11-16$119.45 RISE2022-03-14$36.28 PEAK2022-03-29$50.36 133d | -69.6% 118d | Missed | Missed | — | — | +38.8% 15d | Missed |
1–15 / 21 1 / 2 | |||||||
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers industry, including Astrana Health (NASDAQ:ASTH) and its peers.
Barclays analyst Andrew Mok upgrades Astrana Health (NASDAQ:ASTH) from Equal-Weight to Overweight and raises the price target from $37 to $50.
Earlier in May 2026, Astrana Health reported first-quarter revenue of US$965.1 million and net income of US$14.44 million, reaffirmed its 2026 revenue outlook, announced Chief Medical Officer Dinesh Kumar’s pending resignation, and named George Christides as Interim National Medical Director to oversee population health initiatives. Astrana Health and the Physician Association of California also revealed a collaboration that plugs independent primary care practices into Astrana’s in-house,...
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant industry tailwinds.
Astrana Health’s first quarter was marked by progress in platform integration and the expansion of its AI-driven care model, leading to strong revenue growth and positive market reaction. Management credited the quarter’s momentum to disciplined growth in value-based care, successful integration of the Prospect acquisition, and increasing adoption of full-risk contracts. CEO Brandon Sim noted, “Our results increasingly reflect the advantages of the platform we have built and the way we are embed
Astrana Health, Inc. (NASDAQ:ASTH) is one of the best small cap stocks to buy for 10x potential. On May 8, Baird lifted the price target on Astrana Health, Inc. (NASDAQ:ASTH) to $45 from $40, maintaining an Outperform rating on the shares. The firm updated its model on the stock after it released its fiscal Q1 2026 […]
Truist Securities analyst Jailendra Singh maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $38 to $47.
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Astrana Health (NASDAQ:ASTH) CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected first-quarter trends across medical costs, free cash flow and revenue. Speaking at a Bank of America healthc
Healthcare services company Astrana Health reported revenue ahead of Wall Street’s expectations in Q1 CY2026, with sales up 55.6% year on year to $965.1 million. The company expects next quarter’s revenue to be around $982.5 million, coming in 1% above analysts’ estimates. Its non-GAAP profit of $0.74 per share was 13.8% above analysts’ consensus estimates.
Astrana Health, Inc. (ASTH) Bank of America Global Healthcare Conference 2026 May 12, 2026 6:40 PM EDTCompany ParticipantsBrandon Sim - President &...
Presenter SpeechCraig Jones My name is Craig Jones, I'm the Health Care analyst here at Bank of America. And today, I have the pleasure of hosting Brandon Sim, CEO of Astrana Health. Thanks for
Astrana Health Inc: Astrana Health, Inc. announces appointment of interim national medical director...
Astrana Health, Inc. Announces Appointment of Interim National Medical Director May 12, 2026 4:05pm EDT Download as PDF ALHAMBRA, Calif., May 12, 2026...
TD Cowen analyst Ryan Langston maintains Astrana Health (NASDAQ:ASTH) with a Buy and raises the price target from $35 to $45.
May 2026 ...
Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care May 11, 2026 4:05pm EDT Download as PDF ...
Expands access to Astrana's Medicare ACO platform, powered by a unified AI-powered platform designed for independent physiciansALHAMBRA, Calif., May 11, 2026 /PRNewswire/ -- The Physician Association of California
Barclays analyst Andrew Mok maintains Astrana Health (NASDAQ:ASTH) with a Equal-Weight and raises the price target from $26 to $37.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| ASTH | +7.82% | +42.93% | +51.63% | +51.75% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | +4.86% | +48.65% | +55.08% | +39.07% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 1.65M | $40.47M | 0.00% | Trimmed-1.5% | 2026-03-31 |
| Wellington | fundamental | 1.34M | $32.90M | 0.01% | Added+81.6% | 2026-03-31 |
| FidelityFMR | fundamental | 416.1K | $10.20M | 0.00% | Trimmed-61.1% | 2026-03-31 |
| RenTech | quant | 104.5K | $2.56M | 0.00% | Added+12.2% | 2026-03-31 |
| TRowePrice | fundamental | 49.4K | $1.21K | 0.00% | Added+16.9% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-08-06upcoming | 0.73 | — | — |
| 2026-05-07 | 0.65 | 0.74 | +13.85% |
| 2026-03-02 | 0.33 | 0.42 | +28.58% |
| 2025-11-06 | 0.61 | 0.67 | +10.65% |
| 2025-08-07 | 0.48 | 0.58 | +21.10% |
| 2025-05-08 | 0.33 | 0.44 | +32.54% |
| 2025-02-27 | 0.21 | 0.37 | +79.02% |
| 2024-11-07 | 0.38 | 0.42 | +9.82% |
| 2024-08-07 | 0.56 | 0.45 | -19.62% |
| 2024-05-07 | 0.29 | 0.64 | +120.07% |
| 2024-02-27 | 0.22 | 0.73 | +237.10% |
| 2023-11-07 | 0.32 | 0.47 | +46.88% |
| 2023-08-07 | 0.35 | 0.28 | -20.00% |
| 2023-05-08 | 0.46 | 0.31 | -32.61% |
| 2023-02-23 | -0.23 | -0.06 | +73.91% |
| 2022-11-03 | 0.32 | 0.56 | +75.82% |